The global balloon catheter demand is subjected to growth at a CAGR of 4.3%. The market revenue is likely to be valued at US$ 4.2 Billion in 2023 and exhibit a revenue growth of US$ 6.4 Billion by 2033.
Key players aim at providing balloon catheter technologies that offer the excellent performance required to succeed in difficult circumstances. Furthermore, their exclusive laser-bonded method produces an exceptional TrakTipTM design as well as accurate, smooth bonding along the shaft. These also provide occlusion balloon catheters, which are particularly intended to minimize stone fragment movement down the ureter during PCNL treatments.
Mustang, created by a specific market player, improves patient outcomes because of its reduced sheath diameters. Mustang is meant to facilitate and speed up the operation by having superior cross and track, forceful dilatation, and longer lengths.
To ease strictures and allow the implantation of bigger surgical tools, consumers may always employ a balloon dilatation catheter developed for radial dilatation of the urinary tract. Furthermore, when reaching distant lesions in tiny veins below the knee, end users prefer PTA quick exchange balloon dilatation catheter.
Clinicians may also use the chameleon balloon catheter, which combines the functions of a high-pressure balloon catheter with a diagnostic catheter - allowing for the proximal administration of diagnostic fluids (such as contrast media) and therapeutic fluids. Key companies provide a comprehensive coronary portfolio that includes effective lesion preparation and treatment options. Their next-generation stents and balloon catheters enable polymer-free medication delivery for better clinical outcomes.
Over the previous 12 years, the product family presented by the majority of market participants has proven its functionality and efficacy for coronary lesion treatment, as evidenced by a substantial clinical evidence portfolio comprising more than 110 published studies. A market player recently introduced a next-generation balloon dilatation catheter with high-pressure capacity. It is intended to improve the treatment of patients with coronary artery disease (CAD) during angioplasty treatments.
The product is presently accessible in the United States, Europe, and a few Asian and Latin American countries. The novel method is suitable for both pre-and post-dilatation treatments. VOYAGER NC can be used by physicians to negotiate convoluted anatomy and open up lesions before delivering a stent, or to expand a stent more precisely against the arterial wall once it has been implanted.
Balloon catheters introduced by the key players are designed for stent post- and pre-dilatation of refractory lesions. They also have limited compliance and longitudinal balloon expansion. It is solely employed to dilate the stenotic segment of a coronary artery with a balloon. Moreover, it may be used to bypass graft stenosis to improve myocardial perfusion and for post-dilatation of coronary stents. Some key players have been successful in domestically producing an IABP (Intra-Aortic Balloon Pumping) balloon catheter, a first-aid device for myocardial infarction. They continue to outperform their competitors in the high-tech medical industry.
| Attributes | Details |
|---|---|
| Balloon Catheter Market HCAGR (2017 to 2022) | 3.6% |
| Balloon Catheter Market CAGR (2023 to 2033) | 4.3% |
| Market Size for Balloon Catheter (2023) | US$ 4.2 Billion |
| Market Size for Balloon Catheter (2033) | US$ 6.4 Billion |
According to the World Health Organization (WHO) (2021), cardiovascular disease (CVD) is the leading cause of mortality globally, accounting for an estimated 17.9 Million deaths per year. Similarly, rising demand for minimally invasive operations, as well as an increase in the number of catheterization labs across the area, are likely to drive profitable growth during the projection period.
The majority of cardiovascular problems are treated with treatments such as percutaneous transluminal coronary angioplasty (PTCA), which makes heavy use of PTCA balloon catheters. As a result of the rising frequency of cardiovascular illnesses, a greater number of PCI operations are predicted to be performed. This is expected to create new balloon catheter market trends.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to the data compiled by Future Market Insights, the global forum of balloon catheters has experienced an exceptional growth in recent years. The market's leading providers are working in tandem with the growing demand for balloon catheters. The CAGR rate from 2017 to 2022 was 3.6%, and it is expected to increase to 4.3% during the forecast period.
By raw material type, the market is segmented into polyurethane, nylon, and others. The nylon sector is likely to have a large market share of 4.2% throughout the forecast period, according to Future Market Insights researchers.
The essential elements determining the velocity of this segment are:
Based on indication, the market is segmented into coronary artery disease and peripheral vascular disease. According to Future Market Insights analysts, the coronary artery disease sector is expected to have a larger market share throughout the forecast period and may require the most balloon catheters.
In the United States, balloon catheters are controlled by the Food and Drug Administration (FDA). The Food and Drug Administration and the United States agency in charge of medical device regulation give guidance on requirements for specific Class II applications. Consequently, the FDA's product recall is projected to hamper the market growth.
Principal Consultant
| Country | The United States |
|---|---|
| CAGR (2023 to 2033) | 4.2% |
| HCAGR (2017 to 2022) | 3.5% |
| Country | The United Kingdom |
|---|---|
| CAGR (2023 to 2033) | 4.8% |
| HCAGR (2017 to 2022) | 5.5% |
| Country | Germany |
|---|---|
| CAGR (2023 to 2033) | 4.7% |
| HCAGR (2017 to 2022) | 5.3% |
| Country | China |
|---|---|
| CAGR (2023 to 2033) | 4.8% |
| HCAGR (2017 to 2022) | 4.2% |
| Country | India |
|---|---|
| CAGR (2023 to 2033) | 5.6% |
| HCAGR (2017 to 2022) | 5.3% |
| Attributes | Details |
|---|---|
| USA Market Size (2033) | US$ 1.6 Billion |
| USA Market Absolute Dollar Growth (US$ Million/Billion) | US$ 534.8 Million |
North America is a significant balloon catheter market, particularly in the USA, which holds a revenue share of 4.2%. The value of the balloon catheter market in the USA is estimated to reach a high of US$ 1.6 Billion. This is attributed to the availability of modern healthcare facilities and infrastructure, healthcare spending, and increased patient awareness.
In the United States, consumers choose balloon catheters with low-profile cross-ability and proven clinical effectiveness in crossing stent struts and bifurcations. Furthermore, significant companies provide balloon catheters with innovative shaft and tip technology, as well as an extended-size matrix that improves the balance of trackability and pushability. The key market driver is the number of percutaneous coronary intervention (PCI) operations since a slight drop in the average selling price of devices is projected.
| Attributes | Details |
|---|---|
| The United Kingdom Market Size (2033) | US$ 273.4 Million |
| The United Kingdom Market Absolute Dollar Growth (US$ Million/Billion) | US$ 102.7 Million |
Diabetes prevalence, government efforts, and the release of various technologically improved products by key manufacturers are anticipated to propel the balloon catheter market share in Europe, especially in the United Kingdom and Germany. The United Kingdom produces notable market potential, with a high-paced revenue growth rate of 4.8% and an anticipated value of US$ 273.4 Million, throughout the projection period.
The United Kingdom has a considerable global market share among world-leading providers of high-quality balloon catheters. Their balloon catheters are exceptional in terms of purity, symmetry, and robustness, which are critical for certain medical device applications. Key players in the United Kingdom provide a variety of balloon catheters particularly developed to stop severe posterior nasal bleeding (epistaxis) that cannot be stopped by conventional means. They aspire to advance the area of stroke care via continual, deliberate innovation that yields real results. This is accomplished by focusing on the advancement of less invasive stroke therapeutics.
| Attributes | Details |
|---|---|
| Germany Market Size (2033) | US$ 244.3 Million |
| Germany Market Absolute Dollar Growth (US$ Million/Billion) | US$ 89.8 Million |
Germany is a lucrative balloon catheter market, growing at a profit of 4.7%. The value of the balloon catheter market in Germany is expected to reach a high of US$ 244.3 Million. Germany is home to the most recent generation of drug-eluting balloon technology, which is meant to provide the same level of safety and performance as the best-in-class DES technology.
The core products offered by the key clinicians include stents (balloon-expandable and self-expandable), balloons for coronary and peripheral applications, catheters, and a wide variety of interventional cardiology and radiology accessories. Moreover, they provide components for the medical industry, such as specific tubes and sticky adhesives. They also provide a product search service, which includes the procurement of specialty items.
Key companies provide equipment designed exclusively for use as a Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheter to dilate de novo or restenosis coronary lesions for improving myocardial perfusion and reducing the incidence of restenosis. Furthermore, they provide the most comprehensive selection of PTCA drug-eluting balloon catheters, with balloon diameters ranging from 1.50 mm to 5.00 mm and lengths ranging from 10 mm to 40 mm.
Most key companies establish customer value through their lean organizational structure as medium-sized businesses. As a consequence, response times are reduced, unique client demands are met, and costs are reduced. Hence, they provide German-quality items at extremely reasonable pricing. Their goal is to strengthen the long-term ties with their customers and increase long-term collaborations.
| Attributes | Details |
|---|---|
| China Market Size (2033) | US$ 413.9 Million |
| China Market Absolute Dollar Growth (US$ Million/Billion) | US$ 154.6 Million |
China controls a sizable portion of the balloon catheter market, accounting for 4.8% of total sales. The balloon catheter market in China is expected to reach a peak of US$ 413.9 Million. A few key players claim that the original members of their team are seasoned field professionals from China and the United States.
Their current core teams reputedly have more than a decade of field experience. Key players provide balloon catheters that combine their balloon tubing with 'Earnan Balloon Technology,' which is widely known for innovation and advanced technological solutions. They have pioneered additive manufacturing methods, employing unique techniques and medical-grade materials to produce components with complicated tolerances, geometries, and features.
tart-up companies have introduced advanced technologies to supply premium balloon catheters. This is expected to contribute to the global balloon catheter market growth:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The presence of a significant number of prominent players in various regions contributes to the market growth hugely. Ongoing Research and Development (R&D) operations to develop improved technologies, as well as new product innovation provide more potential for the balloon catheter market share.
Novel Developments:
The market is valued at US$ 4.2 billion in 2023.
The market is estimated to record a CAGR of 4.3% through 2033.
Boston Scientific Inc., Medtronic, and Terumo Corporation are the key market players.
The rise in the number of angioplasty patients is to boost the market prospects.
The nylon segment is likely to remain preferred through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Product, 2017 to 2022
5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Normal Balloon Catheter
5.3.2. Cutting Balloon Catheter
5.3.3. Scoring Balloon Catheter
5.3.4. Drug Eluting Balloon Catheter
5.3.5. Stent Graft Balloon Catheter
5.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Raw Material
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Raw Material, 2017 to 2022
6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Raw Material, 2023 to 2033
6.3.1. Polyurethane
6.3.2. Nylon
6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By Raw Material, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Raw Material, 2023 to 2033
7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Indication, 2017 to 2022
7.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033
7.3.1. Coronary Artery Disease
7.3.2. Peripheral Vascular Disease
7.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2022
7.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
8. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By End User, 2017 to 2022
8.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Hospitals
8.3.1.1. Private Hospitals
8.3.1.2. Public Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Cardiac Catheterization Laboratories
8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2017 to 2022
9.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Eastern Europe
9.3.4. Western Europe
9.3.5. Asia Pacific excluding Japan (APEJ)
9.3.6. Japan
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. The USA
10.2.1.2. Canada
10.2.2. By Product
10.2.3. By Raw Material
10.2.4. By Indication
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Raw Material
10.3.4. By Indication
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product
11.2.3. By Raw Material
11.2.4. By Indication
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Raw Material
11.3.4. By Indication
11.3.5. By End User
11.4. Key Takeaways
12. Eastern Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Raw Material
12.2.4. By Indication
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Raw Material
12.3.4. By Indication
12.3.5. By End User
12.4. Key Takeaways
13. Western Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. U.K.
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Western Europe
13.2.2. By Product
13.2.3. By Raw Material
13.2.4. By Indication
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Raw Material
13.3.4. By Indication
13.3.5. By End User
13.4. Key Takeaways
14. APEJ Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. India
14.2.1.3. A&NZ
14.2.1.4. Rest of APEJ
14.2.2. By Product
14.2.3. By Raw Material
14.2.4. By Indication
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Raw Material
14.3.4. By Indication
14.3.5. By End User
14.4. Key Takeaways
15. Japan Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
15.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.2. By Product
15.2.3. By Raw Material
15.2.4. By Indication
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Raw Material
15.3.4. By Indication
15.3.5. By End User
15.4. Key Takeaways
16. MEA Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
16.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Rest of MEA
16.2.2. By Product
16.2.3. By Raw Material
16.2.4. By Indication
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product
16.3.3. By Raw Material
16.3.4. By Indication
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Analysis
17.1. The USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Product
17.1.2.2. By Raw Material
17.1.2.3. By Indication
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Product
17.2.2.2. By Raw Material
17.2.2.3. By Indication
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Product
17.3.2.2. By Raw Material
17.3.2.3. By Indication
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Product
17.4.2.2. By Raw Material
17.4.2.3. By Indication
17.4.2.4. By End User
17.5. Poland
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Product
17.5.2.2. By Raw Material
17.5.2.3. By Indication
17.5.2.4. By End User
17.6. Russia
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Product
17.6.2.2. By Raw Material
17.6.2.3. By Indication
17.6.2.4. By End User
17.7. Germany
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Product
17.7.2.2. By Raw Material
17.7.2.3. By Indication
17.7.2.4. By End User
17.8. U.K.
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Product
17.8.2.2. By Raw Material
17.8.2.3. By Indication
17.8.2.4. By End User
17.9. France
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Product
17.9.2.2. By Raw Material
17.9.2.3. By Indication
17.9.2.4. By End User
17.10. Spain
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Product
17.10.2.2. By Raw Material
17.10.2.3. By Indication
17.10.2.4. By End User
17.11. Italy
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Product
17.11.2.2. By Raw Material
17.11.2.3. By Indication
17.11.2.4. By End User
17.12. China
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Product
17.12.2.2. By Raw Material
17.12.2.3. By Indication
17.12.2.4. By End User
17.13. India
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Product
17.13.2.2. By Raw Material
17.13.2.3. By Indication
17.13.2.4. By End User
17.14. A&NZ
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Product
17.14.2.2. By Raw Material
17.14.2.3. By Indication
17.14.2.4. By End User
17.15. Japan
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Product
17.15.2.2. By Raw Material
17.15.2.3. By Indication
17.15.2.4. By End User
17.16. GCC Countries
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Product
17.16.2.2. By Raw Material
17.16.2.3. By Indication
17.16.2.4. By End User
17.17. South Africa
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Product
17.17.2.2. By Raw Material
17.17.2.3. By Indication
17.17.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product
18.3.3. By Raw Material
18.3.4. By Indication
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Boston Scientific Inc.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. Medtronic
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. Terumo Corporation
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. B. Braun Melsungen AG
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. MicroPort Scientific Corporation
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. Jotech GmbH
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. QX Medical LLC
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. Meril Life Pvt. Ltd
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. Hexacath
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
19.1.10. Abbott Laboratories
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.10.5.2. Product Strategy
19.1.10.5.3. Channel Strategy
19.1.11. Tokai Medical Products Inc
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.11.5.2. Product Strategy
19.1.11.5.3. Channel Strategy
19.1.12. Biosensors International Ltd.
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.12.5.2. Product Strategy
19.1.12.5.3. Channel Strategy
19.1.13. Cook Medical Inc.
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
19.1.13.5.2. Product Strategy
19.1.13.5.3. Channel Strategy
19.1.14. Cardionovum GmbH.
19.1.14.1. Overview
19.1.14.2. Product Portfolio
19.1.14.3. Profitability by Market Segments
19.1.14.4. Sales Footprint
19.1.14.5. Strategy Overview
19.1.14.5.1. Marketing Strategy
19.1.14.5.2. Product Strategy
19.1.14.5.3. Channel Strategy
19.1.15. Cordis Corporation
19.1.15.1. Overview
19.1.15.2. Product Portfolio
19.1.15.3. Profitability by Market Segments
19.1.15.4. Sales Footprint
19.1.15.5. Strategy Overview
19.1.15.5.1. Marketing Strategy
19.1.15.5.2. Product Strategy
19.1.15.5.3. Channel Strategy
19.1.16. Biotronik
19.1.16.1. Overview
19.1.16.2. Product Portfolio
19.1.16.3. Profitability by Market Segments
19.1.16.4. Sales Footprint
19.1.16.5. Strategy Overview
19.1.16.5.1. Marketing Strategy
19.1.16.5.2. Product Strategy
19.1.16.5.3. Channel Strategy
19.1.17. Nitinol Device & Components Inc.
19.1.17.1. Overview
19.1.17.2. Product Portfolio
19.1.17.3. Profitability by Market Segments
19.1.17.4. Sales Footprint
19.1.17.5. Strategy Overview
19.1.17.5.1. Marketing Strategy
19.1.17.5.2. Product Strategy
19.1.17.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Balloon Catheter Market
